Morgan Stanley
MS
$193.83
+1.02%
Morgan Stanley is a global financial services powerhouse operating across investment banking, institutional trading, wealth management, and asset management. The firm has successfully transformed from a pure-play investment bank into a diversified financial giant, now deriving the majority of its income from its massive wealth and asset management franchises, which oversee trillions in client assets. The current investor narrative is dominated by the firm's ability to capitalize on market volatility, as evidenced by recent record trading results, while simultaneously navigating the performance of its core fee-based wealth and investment management businesses in a complex macroeconomic environment.…
MS
Morgan Stanley
$193.83
Related headlines
Investment Opinion: Should I buy MS Today?
Rating & Thesis: Hold. Morgan Stanley is a high-quality, diversified financial institution executing well, but its valuation following a 62.87% one-year rally appears full, limiting near-term upside and elevating risk. The analyst consensus, reflected in 'Overweight' and 'Outperform' ratings, is positive but the stock price is already testing cycle highs.
Supporting Evidence: The stock trades at a forward P/E of 15.02x and a PEG ratio of 0.58, which suggests growth is reasonably priced. Revenue growth is healthy at 11.08% YoY, and profitability is strong with a net margin of 15.24% and ROE of 15.10%. However, the trailing P/E of 16.54x sits at the upper end of its own historical band, and the price is at 97.7% of its 52-week range, indicating much good news is priced in.
Risks & Conditions: The two biggest risks are valuation multiple contraction from current elevated levels and a cyclical downturn in financial markets impacting fee income. This Hold rating would upgrade to a Buy if the P/E multiple corrected meaningfully below 15x without a deterioration in the growth outlook, or if the stock sustainably broke above the $194.59 resistance on high volume. It would downgrade to a Sell if revenue growth decelerated below 5% YoY or net margins compressed significantly. Relative to its own history and growth profile, the stock is fairly valued to slightly overvalued at current levels.
Sign up to view all
MS 12-Month Price Forecast
The outlook is balanced with a neutral stance. Morgan Stanley's quality and recent performance are undeniable, but the risk/reward at current prices is symmetrical. The base case of modest upside to analyst-driven targets is most probable, but the path is likely volatile given the stock's high beta. The stance would upgrade to bullish on a successful breakout above $194.59 with strong volume, signaling a new leg higher. It would turn bearish if the stock fails to hold support on a market downturn and breaks below key technical levels, suggesting the bull trend has broken.
Wall Street consensus
Most Wall Street analysts maintain a constructive view on Morgan Stanley's 12-month outlook, with a consensus price target around $251.98 and implied upside of +30.0% versus the current price.
Average Target
$251.98
7 analysts
Implied Upside
+30.0%
vs. current price
Analyst Count
7
covering this stock
Price Range
$155 - $252
Analyst target range
Analyst coverage for this large-cap bellwether is substantial, with 7 analysts providing estimates. The consensus sentiment leans bullish, as reflected in recent institutional ratings from firms like Barclays ('Overweight'), Keefe Bruyette & Woods ('Outperform'), and Jefferies ('Buy'), though JP Morgan maintains a 'Neutral' stance. The average revenue estimate for the upcoming period is $93.90 billion, with a range from $90.68 billion to $96.72 billion, indicating a relatively tight spread and strong consensus on the top-line outlook. The target price range is not explicitly provided in the data, but the estimated EPS range is $14.69 to $15.98, with an average of $15.38. The high end of the EPS range likely assumes continued strength in trading, successful net interest income management, and stable asset management fees, while the low end may factor in a potential slowdown in capital markets activity or compression in wealth management margins. The recent pattern of reiterated 'Outperform' and 'Overweight' ratings suggests analysts are affirming their positive view following the company's strong performance.
Bulls vs Bears: MS Investment Factors
The evidence currently leans bullish, driven by robust fundamental performance, a successful business model transformation, and powerful technical momentum. The most compelling bull arguments are the firm's demonstrated ability to turn market volatility into record profits and its stable, fee-based wealth management backbone. However, the bear case presents credible risks centered on valuation, leverage, and cyclical sensitivity. The single most important tension in the investment debate is whether the market is correctly pricing the sustainability of Morgan Stanley's elevated profitability and growth (justifying a P/E at cycle highs) or if the stock is overly reliant on favorable but potentially transient market conditions, setting it up for multiple compression.
Bullish
- Record Trading Performance: Recent geopolitical volatility, as highlighted by a $5.15 billion trading quarter, showcases the firm's ability to capitalize on market dislocations. This demonstrates the strength and resilience of its Institutional Securities division, a key profit driver.
- Strong Revenue & Earnings Growth: The company posted 11.08% YoY revenue growth in its latest quarter, with net income rising from $3.41B to $4.40B over recent quarters. This consistent top-line expansion and bottom-line growth underscore effective execution in a complex environment.
- Diversified, Stable Fee-Based Business: The majority of income now comes from wealth and asset management, overseeing $9.3 trillion in client assets. This provides a stable, recurring revenue stream that is less volatile than pure investment banking, supporting a premium valuation.
- Attractive PEG Ratio: With a trailing PEG ratio of 0.58, the stock appears undervalued relative to its earnings growth rate. This suggests the market may not be fully pricing in the sustainability of its recent performance and diversified model.
Bearish
- Valuation at Cycle Highs: The trailing P/E of 16.54x is at the higher end of its recent historical range (10.7x-15.9x), leaving limited room for multiple expansion. Trading near its 52-week high of $194.59 also increases near-term risk of a pullback.
- Elevated Financial Leverage: A debt-to-equity ratio of 4.26, while typical for a bank, represents significant financial leverage. In a rising rate or economic downturn scenario, this could pressure profitability and increase refinancing risks.
- Negative Free Cash Flow: Trailing-twelve-month free cash flow is negative $17.89 billion, reflecting the capital-intensive nature of its balance sheet activities. This limits financial flexibility for shareholder returns compared to asset-light businesses.
- High Beta & Volatility: A beta of 1.182 indicates the stock is 18% more volatile than the market. Combined with its recent sharp rally, this suggests heightened sensitivity to broader market corrections, which could trigger a significant drawdown.
MS Technical Analysis
The stock is in a sustained long-term uptrend, evidenced by a formidable 1-year price change of +62.87%, significantly outperforming the broader market. As of the latest close, the price of $190.17 positions it at approximately 97.7% of its 52-week range ($117.21 to $194.59), indicating it is trading near its cycle highs and testing a major resistance level. This positioning suggests strong momentum but also raises the risk of a pullback if the stock fails to break through this ceiling. Recent momentum has been exceptionally strong, with the stock surging 14.44% over the past month, sharply accelerating from its 3-month gain of 4.03% and decoupling from the S&P 500's 9.98% monthly return. This powerful short-term rally, which followed a period of consolidation and weakness in February and March, signals a potential resumption of the primary uptrend, though the proximity to the 52-week high warrants caution. Key technical support is anchored at the 52-week low of $117.21, while immediate resistance sits at the 52-week high of $194.59. A decisive breakout above $194.59 would signal a continuation of the bullish trend, whereas a rejection could lead to a consolidation phase. The stock's beta of 1.182 indicates it is approximately 18% more volatile than the S&P 500, which is a critical consideration for risk management, especially given its recent surge and high relative positioning.
Beta
1.21
1.21x market volatility
Max Drawdown
-19.3%
Largest decline past year
52-Week Range
$124-$195
Price range past year
Annual Return
+49.8%
Cumulative gain past year
| Period | MS Return | S&P 500 |
|---|---|---|
| 1m | +7.0% | +8.2% |
| 3m | +15.3% | +9.0% |
| 6m | +18.3% | +10.5% |
| 1y | +49.8% | +26.5% |
| ytd | +6.6% | +8.9% |
Bobby - Your AI Investment Partner
Get real-time data, AI-driven personalized investment analysis to make smarter investment decisions
MS Fundamental Analysis
Revenue growth has been robust, with the most recent quarterly revenue reaching $28.86 billion, representing an 11.08% year-over-year increase. This growth is driven by a diversified model, with the latest segment data showing contributions from Institutional Securities ($7.93B), Wealth Management ($8.43B), and Investment Management ($1.72B). The multi-quarter trend shows revenue has grown from $25.35 billion in Q1 2024 to the current level, indicating a healthy, upward trajectory. The company is highly profitable, posting a net income of $4.40 billion for the latest quarter, translating to a net margin of 15.24%. Gross margin for the quarter was a strong 58.02%, and the operating margin was 19.96%. Profitability has been consistent, with net income rising from $3.41 billion in Q1 2024 to the current $4.40 billion, demonstrating margin stability and effective cost management in a capital-intensive industry. The balance sheet shows a debt-to-equity ratio of 4.26, which is elevated but typical for a leveraged financial institution. Return on Equity (ROE) is a solid 15.10%, indicating efficient use of shareholder capital. However, free cash flow presents a concern, with a trailing-twelve-month figure of negative $17.89 billion, largely due to significant investing and financing activities characteristic of a global bank managing its balance sheet. The current ratio of 1.17 suggests adequate short-term liquidity.
Quarterly Revenue
$28.9B
2025-12
Revenue YoY Growth
+0.11%
YoY Comparison
Gross Margin
+0.58%
Latest Quarter
Free Cash Flow
$-17.9B
Last 12 Months
Revenue & Net Income Trends (2 Years)
Revenue Breakdown
Open an Account, get $2 TSLA now!
Valuation Analysis: Is MS Overvalued?
Given the company's consistent profitability, the primary valuation metric is the Price-to-Earnings (PE) ratio. The trailing PE stands at 16.54x, while the forward PE is slightly lower at 15.02x. The modest discount of the forward multiple suggests the market anticipates stable, but not dramatically accelerating, earnings growth. Compared to sector averages, Morgan Stanley's valuation appears reasonable. Its trailing PE of 16.54x is not explicitly compared to an industry average in the provided data, but its Price-to-Sales (PS) ratio of 2.43x and Price-to-Book (PB) ratio of 2.50x are key metrics for financial firms. The PEG ratio of 0.58, based on trailing earnings, suggests the stock may be undervalued relative to its growth rate if that growth is sustainable. Historically, the stock's own valuation has expanded. The current trailing PE of 16.54x is above its recent historical range observed in the data, which has fluctuated between approximately 10.7x and 15.9x over the past several quarters. Trading near the higher end of its own historical band suggests the market is pricing in improved fundamentals and a favorable outlook, leaving less room for multiple expansion.
PE
16.5x
Latest Quarter
vs. Historical
Mid-Range
5-Year PE Range 8x~25x
vs. Industry Avg
N/A
Industry PE ~N/A*
EV/EBITDA
24.2x
Enterprise Value Multiple
Investment Risk Disclosure
Financial & Operational Risks: Morgan Stanley's primary financial risk stems from its leveraged balance sheet, with a debt-to-equity ratio of 4.26. While standard for a global bank, this magnifies losses in adverse scenarios. The negative $17.89 billion TTM free cash flow, though characteristic of balance sheet management, indicates capital is tied up in operations rather than being returned to shareholders. Furthermore, while diversified, revenue remains exposed to capital markets cycles; a significant slowdown in trading or investment banking could pressure the 15.24% net margin achieved in the latest quarter.
Market & Competitive Risks: The stock faces valuation compression risk, trading at a trailing P/E of 16.54x, which is above its own recent historical range. If growth decelerates or market sentiment sours on financials, this premium could erode. Its beta of 1.182 confirms higher volatility and correlation to market swings. Competitive risks are ever-present from other bulge-bracket banks and fintech disruptors in wealth management. Recent news highlights the firm's success in a volatile geopolitical climate, but this also underscores dependence on such events for trading outperformance.
Worst-Case Scenario: The worst-case scenario involves a severe economic recession coupled with a sustained bear market. This would crush capital markets activity, trigger outflows from wealth management assets, and compress net interest margins. Leverage would amplify the pain on earnings. In this scenario, the stock could realistically revisit its 52-week low of $117.21, representing a downside of approximately -38% from the current price of $190.17. The historical max drawdown of -19.28% over the provided period suggests even intermediate corrections can be sharp, validating this downside risk.
FAQ
The key risks are: 1) Valuation & Cyclical Risk: The stock is trading near cycle highs (P/E 16.54x) and is highly sensitive to financial market health (Beta 1.182). A downturn could trigger significant multiple compression. 2) Financial Leverage: A debt-to-equity ratio of 4.26, while standard, amplifies risks in a crisis. 3) Operational Dependency: Performance is partly tied to volatile trading revenues, as seen with the recent record quarter driven by geopolitical events, which may not be sustainable. 4) Macro Sensitivity: Earnings from wealth management and banking are influenced by interest rates and economic growth.
The 12-month forecast presents three scenarios. The Base Case (60% probability) targets $185-$205, assuming the company hits analyst EPS consensus of $15.38 and the P/E remains stable. The Bull Case (25% probability) targets $205-$225, requiring a breakout above resistance and multiple expansion on sustained outperformance. The Bear Case (15% probability) targets $140-$165, involving an economic slowdown and P/E contraction. The most likely outcome is the Base Case, where earnings growth drives modest appreciation, but the stock remains volatile and range-bound near current levels.
MS appears fairly valued to slightly overvalued based on its own history. Its trailing P/E of 16.54x is above its recent historical range (approximately 10.7x to 15.9x), suggesting the market is pricing in its improved fundamentals. The forward P/E of 15.02x and a PEG ratio of 0.58 indicate the growth-adjusted valuation is more reasonable. Compared to sector peers, its Price-to-Book of 2.50x is a key metric for banks. The valuation implies the market expects the company to maintain its recent strong profitability and growth trajectory, leaving little room for error.
MS is a good stock for investors seeking a high-quality, diversified financial holding, but timing is crucial. At its current price near 52-week highs, the immediate risk/reward is balanced. The stock offers an attractive long-term profile with 11% revenue growth and a 15% ROE, but its 62.87% one-year rally and P/E at the high end of its range suggest waiting for a pullback would provide a better entry point. It is a good buy for long-term investors on weakness, but less attractive for short-term traders at these elevated levels.
MS is better suited for a long-term investment horizon. Its business model transformation towards stable wealth management fees is a multi-year story, and its cyclical businesses require patience through market cycles. The stock's high beta (1.182) and recent surge make it prone to sharp short-term swings, which can punish tactical traders. The lack of a significant dividend yield (2.36%) further reduces its appeal for income-focused short-term holders. A minimum holding period of 3-5 years is recommended to ride out volatility and capture the benefits of its diversified growth strategy.